ArticleJournal of clinical medicine2025

Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease.

Afif Nakhleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.